spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Kidney Transplant Market Soars: Innovative Therapies and Rising Demand Drive Global Growth 2025 | DataM Intelligence

The Kidney Transplant Market is expected to reach at a CAGR of 3.7% during the forecast period 2025-2033.
The Global Kidney Transplant Market is witnessing growth due to rising kidney diseases, advanced surgical techniques, and increasing organ donation awareness worldwide.”

— DataM Intelligence
AUSTIN, TX, UNITED STATES, August 19, 2025 /EINPresswire.com/ — Overview of the Market:
The Global Kidney Transplant Market is experiencing robust growth, driven by the rising prevalence of chronic kidney diseases (CKD), end-stage renal disease (ESRD), and advancements in transplant technology. Kidney transplantation is considered the most effective treatment for patients with ESRD compared to dialysis, offering improved survival rates and quality of life. Increasing awareness about organ donation, government-backed initiatives, and expanding healthcare infrastructure are further boosting the market demand worldwide.

According to DataM Intelligence, the Global Kidney Transplant Market was valued at USD 7.91 billion in 2024 and is expected to reach USD 10.99 billion by 2033, expanding at a CAGR of 3.7% between 2025 and 2033. The rising number of kidney failure cases due to diabetes and hypertension has created a high demand for transplants. North America dominates the market owing to advanced healthcare systems, strong regulatory frameworks, and higher organ donation rates, while the living donor transplant segment remains the largest, given its better long-term success rates compared to deceased donor transplants.

Key Highlights from the Report:
Rising prevalence of chronic kidney disease and end-stage renal failure worldwide.
Living donor transplants hold the largest market share due to higher survival outcomes.

North America leads the market, supported by well-established healthcare facilities.

Growing adoption of advanced immunosuppressive therapies post-transplantation.

Asia-Pacific is expected to register the fastest growth due to increasing healthcare access.
Strategic cooperation and organ donation awareness programs are driving market growth.

Hot this week

Novo Nordisk Lowers Full-Year Profit Guidance in New CEO’s Maiden Quarter

Wegovy-maker Novo Nordisk lowered its full-year profit forecast on...

Compass Pathways to expedite launch timing of its experimental depression therapy

Drug developer Compass Pathways said on Tuesday it is...

Pharma Investment to establish manufacturing facility at SOHAR Freezone

SOHAR Port and Freezone has signed a land lease...

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up

Novo Nordisk and Pfizer have revised their bids for...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img